Retraction Notice to: LINC00472 Acts as a Tumor Suppressor in NSCLC through KLLN-Mediated p53-Signaling Pathway via MicroRNA-149-3p and MicroRNA-4270.

[This retracts the article DOI: 10.1016/j.omtn.2019.06.003.].

Methylation- and homologous recombination deficiency-related mutant genes predict the prognosis of lung adenocarcinoma.

BACKGROUND: Lung adenocarcinoma (LUAD) is a lung cancer subtype with poor prognosis. We investigated the prognostic value of methylation- and homologous recombination deficiency (HRD)-associated gene signatures in LUAD. METHODS: Data on RNA sequencing, somatic mutations, and methylation were obtained from TCGA database. HRD scores were used to stratify patients with LUAD into high and low HRD groups and identify differentially mutated and expressed genes (DMEGs). Pearson correlation analysis between DMEGs and methylation yielded methylation-associated DMEGs. Cox regression analysis was used to construct a prognostic model, and the distribution of clinical features in the high- and low-risk groups was compared. RESULTS: Patients with different HRD scores showed different DNA mutation patterns. There were 272 differentially mutated genes and 6294 differentially expressed genes. Fifty-seven DMEGs were obtained; the top 10 upregulated genes were COL11A1, EXO1, ASPM, COL12A1, COL2A1, COL3A1, COL5A2, DIAPH3, CAD, and SLC25A13, while the top 10 downregulated genes were C7, ERN2, DLC1, SCN7A, SMARCA2, CARD11, LAMA2, ITIH5, FRY, and EPHB6. Forty-two DMEGs were negatively correlated with 259 methylation sites. Gene ontology and pathway enrichment analysis of the DMEGs revealed enrichment of loci involved in extracellular matrix-related remodeling and signaling. Six out of the 42 methylation-associated DMEGs were significantly associated with LUAD prognosis and included in the prognostic model. The model effectively stratified high- and low-risk patients, with the high-risk group having more patients with advanced stage disease. CONCLUSION: We developed a novel prognostic model for LUAD based on methylation and HRD. Methylation-associated DMEGs may function as biomarkers and therapeutic targets for LUAD. Further studies are needed to elucidate their roles in LUAD carcinogenesis.

SHCBP1 promotes cisplatin induced apoptosis resistance, migration and invasion through activating Wnt pathway.

Lung cancer is the leading cause for cancer death due to refractory nature to current treatment strategies, understanding the regulatory mechanism of therapy resistance of lung cancer is important for lung cancer therapy. Here, we aimed to study the role of SHCBP1 in lung cancer cisplatin resistance, we found SHCBP1 was upregulated in lung cancer tissues and cells, patients with high SHCBP1 had poor prognosis. SHC binding and spindle associated 1 (SHCBP1) overexpression promoted cisplatin induced apoptosis resistance, migration and invasion determined by apoptosis assay and transwell assay with or without Matrigel, while SHCBP1 knockdown inhibited cisplatin induced apoptosis resistance, migration and invasion. Wnt pathway promoted lung cancer progression, we found SHCBP1 activated Wnt pathway, characterized by promoting ß-catenin nuclear translocation. Inhibition of Wnt pathway in SHCBP1 overexpression cells reversed the effect of SHCBP1 overexpression, confirming SHCBP1 promoted lung cancer progression through activating Wnt pathway. We also found SHCBP1 expression was positively corrected with Wnt pathway activity in lung cancer samples. In summary, we found SHCBP1 promoted cisplatin induced apoptosis resistance, migration and invasion through activating Wnt pathway, providing a potential target for lung cancer therapy.

LINC00472 Acts as a Tumor Suppressor in NSCLC through KLLN-Mediated p53-Signaling Pathway via MicroRNA-149-3p and MicroRNA-4270.

Long non-coding RNAs and microRNAs (miRNAs) have been reported to participate in the progression of non-small-cell lung cancer (NSCLC). Long intergenic non-protein-coding RNA 472 (LINC00472), miR-149-3p, and miR-4270 were found to be involved in tumor activities, suggesting potential roles in NSCLC. Thus, this study aimed to examine the ability of LINC00472 to influence the progression of NSCLC with the involvement of miR-149-3p and miR-4270. Initially, differentially expressed long non-coding RNAs (lncRNAs), downstream regulatory miRNAs, and genes related to NSCLC were identified. Next, the interaction among LINC00472, miR-149-3p and miR-4270, and KLLN and the p53-signaling pathway was determined. The effect of LINC00472 on the expression of E-cadherin, N-cadherin, and Vimentin was examined through gain-of-function and loss-of-function experiments. Lastly, the effects of LINC00472 on NSCLC tumor growth were assessed in vivo. LINC00472 and KLLN were found to exhibit low levels, while miR-149-3p and miR-4270 were highly expressed in NSCLC. In addition, the overexpression of LINC00472 was observed to upregulate KLLN and activate the p53-signaling pathway, which ultimately inhibited the invasion, migration, and EMT of NSCLC cells via miR-149-3p and miR-4270, corresponding to decreased N-cadherin and Vimentin and increased E-cadherin. The overexpression of LINC00472 exerted an inhibitory effect on tumor growth in vivo. Taken together, the key evidence suggests that the overexpression of LINC00472 can downregulate miR-149-3p and miR-4270 to upregulate KLLN and activate the p53-signaling pathway, thus inhibiting the development of NSCLC. This study highlights the potential of LINC00472 as a promising therapeutic target for NSCLC treatment.

miR-455 inhibits breast cancer cell proliferation through targeting CDK14.

Breast cancer is the most frequently occurring cancer in women worldwide, microRNAs (miRNAs) play critical role in the initiation and progression of breast cancer. Here, we studied the effect of miR-455 on cell proliferation of breast cancer, and found that miR-455 was downregulated in breast cancer tissues and cells. Its overexpression inhibited cell proliferation, whereas its knockdown promoted cell proliferation of breast cancer. We found a Cdc2-related protein kinase CDK14 was the target of miR-455, when the 3'UTR of CDK14 was cloned into luciferase reporter vector and transfected into cells, miR-455 mimic could inhibit the luciferase activity in a dose-dependent manner, miR-455 inhibitor increased the luciferase activity, but the mutant miR-455 mimic couldn't change the luciferase activity, suggesting miR-455 directly bound to the 3'UTR of CDK14. Meanwhile, we also found miR-455 inhibited Cyclin D1 expression and promoted p21 expression, confirming miR-455 inhibited cell proliferation. Double knockdown of miR-455 and CDK14 inhibited the proliferation of breast cancer cell, confirming miR-455 inhibiting cell proliferation by targeting CDK14. Moreover, miR-455 levels were negatively correlated with CDK14 levels in breast cancer tissues. Our finding revealed miR-455 inhibits breast cancer cell proliferation through targeting CDK14, it might be a target for breast cancer therapy.

Live HeLa cells preconcentrate and differentiate inorganic arsenic species.

Live HeLa cells immobilized on Sephadex G-50 beads were used as a medium for the preconcentration and speciation of inorganic arsenic. The sorption of arsenic species by live HeLa cells involves both surface uptake and bioaccumulation within the cells. At pH 3.0, the cells accumulate arsenate with high specificity over arsenite: 83.0 +/- 1.3% of the arsenate was sorbed while the retention of arsenite was negligible at 2.1 +/- 0.6%. The speciation of inorganic arsenic could thus be performed by direct determination of arsenate followed by quantifying total inorganic arsenic after conversion of arsenite to arsenate. We formed a disposable live cell preconcentration microcolumn with the live HeLa cells immobilized on Sephadex G-50 beads. After the sample was passed through the column for sorption to occur, the cells and any retained arsenate were stripped with 2 M HNO(3). The arsenic in the 30 microL eluate was directly measured by graphite furnace atomic absorption spectrometry. A new microcolumn was used for each sample. With a sample volume of 450 muL, a S/N = 3 limit of detection (LOD) of 0.05 microg/L and a linear range of 0.15-2.5 microg/L were attained; the relative standard deviation (RSD) was 1.7% at 1.25 microg/L. The procedure was validated by arsenic speciation in certified reference river water.

Cell-sorption of paramagnetic metal ions on a cell-immobilized micro-column in the presence of an external magnetic field.

The cell-sorption of paramagnetic ions of Mn2+ and Cr3+ onto a Chlorella vulgaris (C. vulgaris) cell-immobilized micro-column was significantly improved in the presence of an external magnetic field generated in a finite solenoid, by placing the micro-column in the center of the solenoid in a sequential injection system. Magnetic field creates an opposite drift velocity on the hydrated paramagnetic ions against the flow of the sample zone, retards the moving velocity of the metal ions and provides extra contacting time with the cells on the micro-column and offers more chances for the paramagnetic ions to interact with the various functional groups or binding sites on the cell surface, which significantly facilitates cell-sorption of the paramagnetic ions. The sorption efficiencies of Mn2+ and Cr3+ at the 20 microg L(-1) level were improved from 45 to 80% and 60 to 90%, respectively, in a magnetic field of 240 mT. The system was applied for the separation/preconcentration of ultra-trace level of manganese. The presence of an external magnetic field significantly alleviated the interfering effects from coexisting metal ions. Within a liner range of 0.025-0.5 microg L(-1) and a sampling volume of 500 microL, an enrichment factor of 21.2, a limit of detection of 0.008 microg L(-1), along with a sampling frequency of 20 h(-1) was attained, achieving a precision of 2.1% R.S.D. (0.2 microg L(-1)). Manganese contents in a certified reference material of riverine water and a snow water were analyzed.

Hyphenation of flow injection/sequential injection with chemical hydride/vapor generation atomic fluorescence spectrometry.

The dominant role played by flow injection/sequential injection (FI/SI, including lab-on-valve, LOV) in automatic on-line sample pretreatments coupling to various detection techniques is amply demonstrated by the large number of publications it has given rise to. Among these, its hyphenation with hydride/vapor generation atomic fluorescence spectrometry (HG/VG-AFS) has become one of the most attractive sub-branches during the last years, attributed not only to the high sensitivity of this technique, but also to the superb separation capability of hydride/vapor forming elements from complex sample matrices. In addition, it also provides potentials for the speciation of the elements of interest. It is worth mentioning that quite a few novel developments of sample pretreatment have emerged recently, which attracted extensive attentions from the related fields of research. The aim of this mini-review is thus to illustrate the state-of-the-art progress of implementing flow injection/sequential injection and miniaturized lab-on-valve systems for on-line hydride/vapor generation separation and preconcentration of vapor forming elements followed with detection by atomic fluorescence spectrometry, within the period from 2004 up to now. Future perspectives in this field are also discussed.